nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabergoline—Pleurisy—Methotrexate—muscle cancer	0.0232	0.0275	CcSEcCtD
Cabergoline—Pulmonary fibrosis—Etoposide—muscle cancer	0.0215	0.0255	CcSEcCtD
Cabergoline—Gravitational oedema—Doxorubicin—muscle cancer	0.0201	0.0238	CcSEcCtD
Cabergoline—Fibrosis—Methotrexate—muscle cancer	0.0198	0.0235	CcSEcCtD
Cabergoline—Leg edema—Doxorubicin—muscle cancer	0.0182	0.0216	CcSEcCtD
Cabergoline—Pericardial effusion—Methotrexate—muscle cancer	0.0138	0.0164	CcSEcCtD
Cabergoline—Pericarditis—Methotrexate—muscle cancer	0.0131	0.0155	CcSEcCtD
Cabergoline—Pulmonary fibrosis—Methotrexate—muscle cancer	0.0129	0.0153	CcSEcCtD
Cabergoline—Pericardial effusion—Doxorubicin—muscle cancer	0.0119	0.0142	CcSEcCtD
Cabergoline—Respiratory failure—Vincristine—muscle cancer	0.0119	0.0141	CcSEcCtD
Cabergoline—Musculoskeletal pain—Vincristine—muscle cancer	0.0118	0.014	CcSEcCtD
Cabergoline—Prostatic disorder—Doxorubicin—muscle cancer	0.0115	0.0137	CcSEcCtD
Cabergoline—Pericarditis—Doxorubicin—muscle cancer	0.0113	0.0134	CcSEcCtD
Cabergoline—HTR2A—hindlimb—muscle cancer	0.0104	0.066	CbGeAlD
Cabergoline—HTR2A—appendage—muscle cancer	0.00888	0.0566	CbGeAlD
Cabergoline—Liver function test abnormal—Dactinomycin—muscle cancer	0.00874	0.0104	CcSEcCtD
Cabergoline—Pleural effusion—Methotrexate—muscle cancer	0.00739	0.00876	CcSEcCtD
Cabergoline—DRD4—testis—muscle cancer	0.00736	0.0469	CbGeAlD
Cabergoline—Pneumonia—Dactinomycin—muscle cancer	0.00734	0.00871	CcSEcCtD
Cabergoline—Hypokinesia—Doxorubicin—muscle cancer	0.00726	0.00861	CcSEcCtD
Cabergoline—Cardiac failure—Etoposide—muscle cancer	0.00702	0.00833	CcSEcCtD
Cabergoline—Weight decreased—Vincristine—muscle cancer	0.00662	0.00785	CcSEcCtD
Cabergoline—Pneumonia—Vincristine—muscle cancer	0.00656	0.00778	CcSEcCtD
Cabergoline—Depression—Vincristine—muscle cancer	0.0065	0.00771	CcSEcCtD
Cabergoline—Pleural effusion—Doxorubicin—muscle cancer	0.0064	0.00759	CcSEcCtD
Cabergoline—ADRA1B—renal system—muscle cancer	0.00615	0.0392	CbGeAlD
Cabergoline—Hallucination—Vincristine—muscle cancer	0.00583	0.00691	CcSEcCtD
Cabergoline—Alopecia—Dactinomycin—muscle cancer	0.00579	0.00687	CcSEcCtD
Cabergoline—Sweating increased—Etoposide—muscle cancer	0.00577	0.00685	CcSEcCtD
Cabergoline—Respiratory failure—Methotrexate—muscle cancer	0.00576	0.00683	CcSEcCtD
Cabergoline—Neoplasm malignant—Doxorubicin—muscle cancer	0.00574	0.0068	CcSEcCtD
Cabergoline—Breast pain—Doxorubicin—muscle cancer	0.00561	0.00666	CcSEcCtD
Cabergoline—Cardiac disorder—Vincristine—muscle cancer	0.00543	0.00644	CcSEcCtD
Cabergoline—Arthropathy—Doxorubicin—muscle cancer	0.00539	0.00639	CcSEcCtD
Cabergoline—DRD3—head—muscle cancer	0.00535	0.0341	CbGeAlD
Cabergoline—Pneumonia—Etoposide—muscle cancer	0.00531	0.0063	CcSEcCtD
Cabergoline—Ill-defined disorder—Dactinomycin—muscle cancer	0.00529	0.00628	CcSEcCtD
Cabergoline—Dyskinesia—Doxorubicin—muscle cancer	0.00521	0.00618	CcSEcCtD
Cabergoline—Alopecia—Vincristine—muscle cancer	0.00517	0.00614	CcSEcCtD
Cabergoline—Malaise—Dactinomycin—muscle cancer	0.00514	0.0061	CcSEcCtD
Cabergoline—DRD5—head—muscle cancer	0.00502	0.032	CbGeAlD
Cabergoline—Musculoskeletal pain—Doxorubicin—muscle cancer	0.00496	0.00588	CcSEcCtD
Cabergoline—Back pain—Vincristine—muscle cancer	0.00493	0.00585	CcSEcCtD
Cabergoline—Discomfort—Dactinomycin—muscle cancer	0.0048	0.00569	CcSEcCtD
Cabergoline—Influenza like illness—Doxorubicin—muscle cancer	0.00476	0.00564	CcSEcCtD
Cabergoline—Oedema—Dactinomycin—muscle cancer	0.00466	0.00552	CcSEcCtD
Cabergoline—Vertigo—Vincristine—muscle cancer	0.00458	0.00543	CcSEcCtD
Cabergoline—Cramps of lower extremities—Doxorubicin—muscle cancer	0.0045	0.00534	CcSEcCtD
Cabergoline—Anorexia—Dactinomycin—muscle cancer	0.00444	0.00526	CcSEcCtD
Cabergoline—Cardiac disorder—Etoposide—muscle cancer	0.0044	0.00522	CcSEcCtD
Cabergoline—Hypertension—Vincristine—muscle cancer	0.0044	0.00522	CcSEcCtD
Cabergoline—HTR2B—smooth muscle tissue—muscle cancer	0.00434	0.0277	CbGeAlD
Cabergoline—Abnormal vision—Doxorubicin—muscle cancer	0.00427	0.00507	CcSEcCtD
Cabergoline—Mental disability—Doxorubicin—muscle cancer	0.00425	0.00504	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00424	0.00503	CcSEcCtD
Cabergoline—Alopecia—Etoposide—muscle cancer	0.00419	0.00497	CcSEcCtD
Cabergoline—Oedema—Vincristine—muscle cancer	0.00416	0.00493	CcSEcCtD
Cabergoline—ADRA1B—head—muscle cancer	0.00411	0.0262	CbGeAlD
Cabergoline—Osteoarthritis—Methotrexate—muscle cancer	0.00411	0.00487	CcSEcCtD
Cabergoline—Hepatic function abnormal—Doxorubicin—muscle cancer	0.00407	0.00483	CcSEcCtD
Cabergoline—Decreased appetite—Dactinomycin—muscle cancer	0.00405	0.0048	CcSEcCtD
Cabergoline—ADRA1D—head—muscle cancer	0.00402	0.0257	CbGeAlD
Cabergoline—Hyperhidrosis—Vincristine—muscle cancer	0.00402	0.00477	CcSEcCtD
Cabergoline—Fatigue—Dactinomycin—muscle cancer	0.00401	0.00476	CcSEcCtD
Cabergoline—Back pain—Etoposide—muscle cancer	0.00399	0.00474	CcSEcCtD
Cabergoline—Pain—Dactinomycin—muscle cancer	0.00398	0.00472	CcSEcCtD
Cabergoline—Muscle spasms—Etoposide—muscle cancer	0.00397	0.00471	CcSEcCtD
Cabergoline—Anorexia—Vincristine—muscle cancer	0.00396	0.0047	CcSEcCtD
Cabergoline—ADRB1—cardiac atrium—muscle cancer	0.00391	0.0249	CbGeAlD
Cabergoline—Hypotension—Vincristine—muscle cancer	0.00389	0.00461	CcSEcCtD
Cabergoline—Feeling abnormal—Dactinomycin—muscle cancer	0.00384	0.00455	CcSEcCtD
Cabergoline—DRD1—head—muscle cancer	0.00383	0.0244	CbGeAlD
Cabergoline—Ill-defined disorder—Etoposide—muscle cancer	0.00383	0.00454	CcSEcCtD
Cabergoline—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00381	0.00451	CcSEcCtD
Cabergoline—Hot flush—Doxorubicin—muscle cancer	0.0038	0.00451	CcSEcCtD
Cabergoline—Liver function test abnormal—Methotrexate—muscle cancer	0.00379	0.0045	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00379	0.00449	CcSEcCtD
Cabergoline—Menopausal symptoms—Doxorubicin—muscle cancer	0.00377	0.00447	CcSEcCtD
Cabergoline—Insomnia—Vincristine—muscle cancer	0.00376	0.00446	CcSEcCtD
Cabergoline—HTR1A—renal system—muscle cancer	0.00375	0.0239	CbGeAlD
Cabergoline—Paraesthesia—Vincristine—muscle cancer	0.00373	0.00443	CcSEcCtD
Cabergoline—Malaise—Etoposide—muscle cancer	0.00372	0.00442	CcSEcCtD
Cabergoline—HTR7—smooth muscle tissue—muscle cancer	0.00372	0.0237	CbGeAlD
Cabergoline—Vertigo—Etoposide—muscle cancer	0.00371	0.0044	CcSEcCtD
Cabergoline—Abdominal pain—Dactinomycin—muscle cancer	0.00368	0.00436	CcSEcCtD
Cabergoline—Cardiac failure—Doxorubicin—muscle cancer	0.00364	0.00432	CcSEcCtD
Cabergoline—Loss of consciousness—Etoposide—muscle cancer	0.00363	0.0043	CcSEcCtD
Cabergoline—Decreased appetite—Vincristine—muscle cancer	0.00362	0.00429	CcSEcCtD
Cabergoline—Fatigue—Vincristine—muscle cancer	0.00359	0.00425	CcSEcCtD
Cabergoline—HTR7—renal system—muscle cancer	0.00358	0.0228	CbGeAlD
Cabergoline—Hypertension—Etoposide—muscle cancer	0.00356	0.00423	CcSEcCtD
Cabergoline—Pain—Vincristine—muscle cancer	0.00356	0.00422	CcSEcCtD
Cabergoline—Constipation—Vincristine—muscle cancer	0.00356	0.00422	CcSEcCtD
Cabergoline—Osteoarthritis—Doxorubicin—muscle cancer	0.00356	0.00422	CcSEcCtD
Cabergoline—Discomfort—Etoposide—muscle cancer	0.00347	0.00412	CcSEcCtD
Cabergoline—ADRA1A—renal system—muscle cancer	0.00345	0.022	CbGeAlD
Cabergoline—Face oedema—Doxorubicin—muscle cancer	0.00343	0.00407	CcSEcCtD
Cabergoline—Hypersensitivity—Dactinomycin—muscle cancer	0.00343	0.00407	CcSEcCtD
Cabergoline—Abdominal discomfort—Methotrexate—muscle cancer	0.0034	0.00404	CcSEcCtD
Cabergoline—Gastrointestinal pain—Vincristine—muscle cancer	0.0034	0.00403	CcSEcCtD
Cabergoline—Confusional state—Etoposide—muscle cancer	0.0034	0.00403	CcSEcCtD
Cabergoline—Asthenia—Dactinomycin—muscle cancer	0.00334	0.00396	CcSEcCtD
Cabergoline—Blood creatinine increased—Doxorubicin—muscle cancer	0.00333	0.00395	CcSEcCtD
Cabergoline—Upper respiratory tract infection—Methotrexate—muscle cancer	0.0033	0.00391	CcSEcCtD
Cabergoline—ADRA2C—renal system—muscle cancer	0.00329	0.021	CbGeAlD
Cabergoline—Abdominal pain—Vincristine—muscle cancer	0.00329	0.0039	CcSEcCtD
Cabergoline—Liver function test abnormal—Doxorubicin—muscle cancer	0.00328	0.00389	CcSEcCtD
Cabergoline—HTR2B—tendon—muscle cancer	0.00326	0.0208	CbGeAlD
Cabergoline—Hyperhidrosis—Etoposide—muscle cancer	0.00326	0.00386	CcSEcCtD
Cabergoline—Orthostatic hypotension—Doxorubicin—muscle cancer	0.00325	0.00385	CcSEcCtD
Cabergoline—Abdominal pain upper—Doxorubicin—muscle cancer	0.00325	0.00385	CcSEcCtD
Cabergoline—Anorexia—Etoposide—muscle cancer	0.00321	0.00381	CcSEcCtD
Cabergoline—Diarrhoea—Dactinomycin—muscle cancer	0.00319	0.00378	CcSEcCtD
Cabergoline—Pneumonia—Methotrexate—muscle cancer	0.00318	0.00377	CcSEcCtD
Cabergoline—Depression—Methotrexate—muscle cancer	0.00316	0.00374	CcSEcCtD
Cabergoline—Hypotension—Etoposide—muscle cancer	0.00315	0.00373	CcSEcCtD
Cabergoline—Gastritis—Doxorubicin—muscle cancer	0.00315	0.00373	CcSEcCtD
Cabergoline—HTR1B—head—muscle cancer	0.00311	0.0198	CbGeAlD
Cabergoline—Influenza—Doxorubicin—muscle cancer	0.00307	0.00364	CcSEcCtD
Cabergoline—Hypersensitivity—Vincristine—muscle cancer	0.00306	0.00363	CcSEcCtD
Cabergoline—HTR2B—vagina—muscle cancer	0.00303	0.0193	CbGeAlD
Cabergoline—Paraesthesia—Etoposide—muscle cancer	0.00303	0.00359	CcSEcCtD
Cabergoline—HTR1D—head—muscle cancer	0.00301	0.0192	CbGeAlD
Cabergoline—Dyspnoea—Etoposide—muscle cancer	0.003	0.00356	CcSEcCtD
Cabergoline—Somnolence—Etoposide—muscle cancer	0.003	0.00355	CcSEcCtD
Cabergoline—Epistaxis—Methotrexate—muscle cancer	0.00298	0.00354	CcSEcCtD
Cabergoline—Asthenia—Vincristine—muscle cancer	0.00298	0.00354	CcSEcCtD
Cabergoline—HTR2C—head—muscle cancer	0.00298	0.019	CbGeAlD
Cabergoline—Vomiting—Dactinomycin—muscle cancer	0.00296	0.00351	CcSEcCtD
Cabergoline—Bronchitis—Doxorubicin—muscle cancer	0.00296	0.00351	CcSEcCtD
Cabergoline—HTR2A—embryo—muscle cancer	0.00295	0.0188	CbGeAlD
Cabergoline—ADRA2C—cardiac atrium—muscle cancer	0.00295	0.0188	CbGeAlD
Cabergoline—Rash—Dactinomycin—muscle cancer	0.00294	0.00348	CcSEcCtD
Cabergoline—Decreased appetite—Etoposide—muscle cancer	0.00293	0.00347	CcSEcCtD
Cabergoline—ADRB1—head—muscle cancer	0.00292	0.0186	CbGeAlD
Cabergoline—Fatigue—Etoposide—muscle cancer	0.0029	0.00345	CcSEcCtD
Cabergoline—Constipation—Etoposide—muscle cancer	0.00288	0.00342	CcSEcCtD
Cabergoline—Pain—Etoposide—muscle cancer	0.00288	0.00342	CcSEcCtD
Cabergoline—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00286	0.00339	CcSEcCtD
Cabergoline—Diarrhoea—Vincristine—muscle cancer	0.00285	0.00338	CcSEcCtD
Cabergoline—HTR2B—head—muscle cancer	0.0028	0.0178	CbGeAlD
Cabergoline—Weight increased—Doxorubicin—muscle cancer	0.0028	0.00332	CcSEcCtD
Cabergoline—HTR7—tendon—muscle cancer	0.0028	0.0178	CbGeAlD
Cabergoline—Weight decreased—Doxorubicin—muscle cancer	0.00278	0.0033	CcSEcCtD
Cabergoline—Feeling abnormal—Etoposide—muscle cancer	0.00278	0.00329	CcSEcCtD
Cabergoline—Nausea—Dactinomycin—muscle cancer	0.00277	0.00328	CcSEcCtD
Cabergoline—Pneumonia—Doxorubicin—muscle cancer	0.00276	0.00327	CcSEcCtD
Cabergoline—Gastrointestinal pain—Etoposide—muscle cancer	0.00276	0.00327	CcSEcCtD
Cabergoline—Dizziness—Vincristine—muscle cancer	0.00275	0.00326	CcSEcCtD
Cabergoline—Visual impairment—Methotrexate—muscle cancer	0.00274	0.00325	CcSEcCtD
Cabergoline—Abdominal pain—Etoposide—muscle cancer	0.00266	0.00316	CcSEcCtD
Cabergoline—Urinary tract infection—Doxorubicin—muscle cancer	0.00266	0.00316	CcSEcCtD
Cabergoline—Vomiting—Vincristine—muscle cancer	0.00264	0.00314	CcSEcCtD
Cabergoline—Cardiac disorder—Methotrexate—muscle cancer	0.00264	0.00313	CcSEcCtD
Cabergoline—Rash—Vincristine—muscle cancer	0.00262	0.00311	CcSEcCtD
Cabergoline—Dermatitis—Vincristine—muscle cancer	0.00262	0.00311	CcSEcCtD
Cabergoline—Headache—Vincristine—muscle cancer	0.00261	0.00309	CcSEcCtD
Cabergoline—Epistaxis—Doxorubicin—muscle cancer	0.00258	0.00307	CcSEcCtD
Cabergoline—ADRA2C—tendon—muscle cancer	0.00257	0.0164	CbGeAlD
Cabergoline—Alopecia—Methotrexate—muscle cancer	0.00251	0.00298	CcSEcCtD
Cabergoline—HTR1A—head—muscle cancer	0.00251	0.016	CbGeAlD
Cabergoline—Hypersensitivity—Etoposide—muscle cancer	0.00248	0.00294	CcSEcCtD
Cabergoline—Nausea—Vincristine—muscle cancer	0.00247	0.00293	CcSEcCtD
Cabergoline—Rhinitis—Doxorubicin—muscle cancer	0.00247	0.00292	CcSEcCtD
Cabergoline—Oedema peripheral—Doxorubicin—muscle cancer	0.00242	0.00287	CcSEcCtD
Cabergoline—Asthenia—Etoposide—muscle cancer	0.00242	0.00287	CcSEcCtD
Cabergoline—HTR7—head—muscle cancer	0.0024	0.0153	CbGeAlD
Cabergoline—Back pain—Methotrexate—muscle cancer	0.00239	0.00284	CcSEcCtD
Cabergoline—ADRA2C—vagina—muscle cancer	0.00238	0.0152	CbGeAlD
Cabergoline—Pruritus—Etoposide—muscle cancer	0.00238	0.00283	CcSEcCtD
Cabergoline—Visual impairment—Doxorubicin—muscle cancer	0.00237	0.00281	CcSEcCtD
Cabergoline—ADRA2A—cardiac atrium—muscle cancer	0.00235	0.015	CbGeAlD
Cabergoline—HTR2A—smooth muscle tissue—muscle cancer	0.00232	0.0148	CbGeAlD
Cabergoline—HTR7—testis—muscle cancer	0.00231	0.0148	CbGeAlD
Cabergoline—ADRA1A—head—muscle cancer	0.00231	0.0147	CbGeAlD
Cabergoline—Diarrhoea—Etoposide—muscle cancer	0.00231	0.00273	CcSEcCtD
Cabergoline—Ill-defined disorder—Methotrexate—muscle cancer	0.00229	0.00272	CcSEcCtD
Cabergoline—Cardiac disorder—Doxorubicin—muscle cancer	0.00228	0.00271	CcSEcCtD
Cabergoline—DRD2—head—muscle cancer	0.00227	0.0144	CbGeAlD
Cabergoline—HTR2A—renal system—muscle cancer	0.00223	0.0142	CbGeAlD
Cabergoline—Malaise—Methotrexate—muscle cancer	0.00223	0.00264	CcSEcCtD
Cabergoline—Dizziness—Etoposide—muscle cancer	0.00223	0.00264	CcSEcCtD
Cabergoline—Vertigo—Methotrexate—muscle cancer	0.00222	0.00263	CcSEcCtD
Cabergoline—ADRA2C—head—muscle cancer	0.0022	0.014	CbGeAlD
Cabergoline—Arrhythmia—Doxorubicin—muscle cancer	0.0022	0.00261	CcSEcCtD
Cabergoline—DRD2—testis—muscle cancer	0.00219	0.014	CbGeAlD
Cabergoline—Alopecia—Doxorubicin—muscle cancer	0.00217	0.00258	CcSEcCtD
Cabergoline—Vomiting—Etoposide—muscle cancer	0.00214	0.00254	CcSEcCtD
Cabergoline—ADRA2C—testis—muscle cancer	0.00213	0.0136	CbGeAlD
Cabergoline—Rash—Etoposide—muscle cancer	0.00212	0.00252	CcSEcCtD
Cabergoline—Dermatitis—Etoposide—muscle cancer	0.00212	0.00252	CcSEcCtD
Cabergoline—Headache—Etoposide—muscle cancer	0.00211	0.0025	CcSEcCtD
Cabergoline—Flatulence—Doxorubicin—muscle cancer	0.00211	0.0025	CcSEcCtD
Cabergoline—Arthralgia—Methotrexate—muscle cancer	0.00211	0.0025	CcSEcCtD
Cabergoline—Tension—Doxorubicin—muscle cancer	0.0021	0.00249	CcSEcCtD
Cabergoline—Discomfort—Methotrexate—muscle cancer	0.00208	0.00247	CcSEcCtD
Cabergoline—Nervousness—Doxorubicin—muscle cancer	0.00208	0.00247	CcSEcCtD
Cabergoline—Back pain—Doxorubicin—muscle cancer	0.00207	0.00246	CcSEcCtD
Cabergoline—CYP3A4—renal system—muscle cancer	0.00207	0.0132	CbGeAlD
Cabergoline—Muscle spasms—Doxorubicin—muscle cancer	0.00206	0.00244	CcSEcCtD
Cabergoline—ADRA2A—tendon—muscle cancer	0.00205	0.0131	CbGeAlD
Cabergoline—Confusional state—Methotrexate—muscle cancer	0.00203	0.00241	CcSEcCtD
Cabergoline—Nausea—Etoposide—muscle cancer	0.002	0.00237	CcSEcCtD
Cabergoline—Ill-defined disorder—Doxorubicin—muscle cancer	0.00199	0.00236	CcSEcCtD
Cabergoline—Hyperhidrosis—Methotrexate—muscle cancer	0.00195	0.00231	CcSEcCtD
Cabergoline—Malaise—Doxorubicin—muscle cancer	0.00193	0.00229	CcSEcCtD
Cabergoline—Vertigo—Doxorubicin—muscle cancer	0.00192	0.00228	CcSEcCtD
Cabergoline—Anorexia—Methotrexate—muscle cancer	0.00192	0.00228	CcSEcCtD
Cabergoline—Syncope—Doxorubicin—muscle cancer	0.00192	0.00228	CcSEcCtD
Cabergoline—ADRA2A—vagina—muscle cancer	0.0019	0.0121	CbGeAlD
Cabergoline—Palpitations—Doxorubicin—muscle cancer	0.00189	0.00224	CcSEcCtD
Cabergoline—Hypotension—Methotrexate—muscle cancer	0.00189	0.00224	CcSEcCtD
Cabergoline—Loss of consciousness—Doxorubicin—muscle cancer	0.00188	0.00223	CcSEcCtD
Cabergoline—Hypertension—Doxorubicin—muscle cancer	0.00185	0.00219	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00184	0.00218	CcSEcCtD
Cabergoline—Insomnia—Methotrexate—muscle cancer	0.00183	0.00216	CcSEcCtD
Cabergoline—Arthralgia—Doxorubicin—muscle cancer	0.00182	0.00216	CcSEcCtD
Cabergoline—Anxiety—Doxorubicin—muscle cancer	0.00182	0.00215	CcSEcCtD
Cabergoline—Paraesthesia—Methotrexate—muscle cancer	0.00181	0.00215	CcSEcCtD
Cabergoline—Discomfort—Doxorubicin—muscle cancer	0.0018	0.00214	CcSEcCtD
Cabergoline—Dyspnoea—Methotrexate—muscle cancer	0.0018	0.00213	CcSEcCtD
Cabergoline—Somnolence—Methotrexate—muscle cancer	0.00179	0.00213	CcSEcCtD
Cabergoline—Dry mouth—Doxorubicin—muscle cancer	0.00178	0.00211	CcSEcCtD
Cabergoline—Dyspepsia—Methotrexate—muscle cancer	0.00178	0.00211	CcSEcCtD
Cabergoline—Confusional state—Doxorubicin—muscle cancer	0.00176	0.00209	CcSEcCtD
Cabergoline—ADRA2A—head—muscle cancer	0.00176	0.0112	CbGeAlD
Cabergoline—Decreased appetite—Methotrexate—muscle cancer	0.00175	0.00208	CcSEcCtD
Cabergoline—Oedema—Doxorubicin—muscle cancer	0.00175	0.00207	CcSEcCtD
Cabergoline—HTR2A—tendon—muscle cancer	0.00174	0.0111	CbGeAlD
Cabergoline—Fatigue—Methotrexate—muscle cancer	0.00174	0.00206	CcSEcCtD
Cabergoline—Pain—Methotrexate—muscle cancer	0.00173	0.00205	CcSEcCtD
Cabergoline—Shock—Doxorubicin—muscle cancer	0.00172	0.00204	CcSEcCtD
Cabergoline—ADRA2A—testis—muscle cancer	0.0017	0.0108	CbGeAlD
Cabergoline—Hyperhidrosis—Doxorubicin—muscle cancer	0.00169	0.002	CcSEcCtD
Cabergoline—Anorexia—Doxorubicin—muscle cancer	0.00167	0.00198	CcSEcCtD
Cabergoline—Feeling abnormal—Methotrexate—muscle cancer	0.00166	0.00197	CcSEcCtD
Cabergoline—Gastrointestinal pain—Methotrexate—muscle cancer	0.00165	0.00196	CcSEcCtD
Cabergoline—Hypotension—Doxorubicin—muscle cancer	0.00163	0.00194	CcSEcCtD
Cabergoline—HTR2A—vagina—muscle cancer	0.00162	0.0103	CbGeAlD
Cabergoline—Abdominal pain—Methotrexate—muscle cancer	0.0016	0.00189	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00159	0.00189	CcSEcCtD
Cabergoline—Insomnia—Doxorubicin—muscle cancer	0.00158	0.00187	CcSEcCtD
Cabergoline—Paraesthesia—Doxorubicin—muscle cancer	0.00157	0.00186	CcSEcCtD
Cabergoline—Dyspnoea—Doxorubicin—muscle cancer	0.00156	0.00185	CcSEcCtD
Cabergoline—Somnolence—Doxorubicin—muscle cancer	0.00155	0.00184	CcSEcCtD
Cabergoline—Dyspepsia—Doxorubicin—muscle cancer	0.00154	0.00182	CcSEcCtD
Cabergoline—Decreased appetite—Doxorubicin—muscle cancer	0.00152	0.0018	CcSEcCtD
Cabergoline—Fatigue—Doxorubicin—muscle cancer	0.00151	0.00179	CcSEcCtD
Cabergoline—Constipation—Doxorubicin—muscle cancer	0.00149	0.00177	CcSEcCtD
Cabergoline—Pain—Doxorubicin—muscle cancer	0.00149	0.00177	CcSEcCtD
Cabergoline—HTR2A—head—muscle cancer	0.00149	0.00953	CbGeAlD
Cabergoline—Hypersensitivity—Methotrexate—muscle cancer	0.00149	0.00176	CcSEcCtD
Cabergoline—Asthenia—Methotrexate—muscle cancer	0.00145	0.00172	CcSEcCtD
Cabergoline—HTR2A—testis—muscle cancer	0.00144	0.0092	CbGeAlD
Cabergoline—Feeling abnormal—Doxorubicin—muscle cancer	0.00144	0.00171	CcSEcCtD
Cabergoline—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00143	0.00169	CcSEcCtD
Cabergoline—Pruritus—Methotrexate—muscle cancer	0.00143	0.00169	CcSEcCtD
Cabergoline—Abdominal pain—Doxorubicin—muscle cancer	0.00138	0.00164	CcSEcCtD
Cabergoline—Diarrhoea—Methotrexate—muscle cancer	0.00138	0.00164	CcSEcCtD
Cabergoline—Dizziness—Methotrexate—muscle cancer	0.00133	0.00158	CcSEcCtD
Cabergoline—Hypersensitivity—Doxorubicin—muscle cancer	0.00129	0.00153	CcSEcCtD
Cabergoline—Vomiting—Methotrexate—muscle cancer	0.00128	0.00152	CcSEcCtD
Cabergoline—Rash—Methotrexate—muscle cancer	0.00127	0.00151	CcSEcCtD
Cabergoline—Dermatitis—Methotrexate—muscle cancer	0.00127	0.00151	CcSEcCtD
Cabergoline—Headache—Methotrexate—muscle cancer	0.00126	0.0015	CcSEcCtD
Cabergoline—Asthenia—Doxorubicin—muscle cancer	0.00125	0.00149	CcSEcCtD
Cabergoline—Pruritus—Doxorubicin—muscle cancer	0.00124	0.00147	CcSEcCtD
Cabergoline—Nausea—Methotrexate—muscle cancer	0.0012	0.00142	CcSEcCtD
Cabergoline—Diarrhoea—Doxorubicin—muscle cancer	0.0012	0.00142	CcSEcCtD
Cabergoline—Dizziness—Doxorubicin—muscle cancer	0.00116	0.00137	CcSEcCtD
Cabergoline—Vomiting—Doxorubicin—muscle cancer	0.00111	0.00132	CcSEcCtD
Cabergoline—Rash—Doxorubicin—muscle cancer	0.0011	0.00131	CcSEcCtD
Cabergoline—Dermatitis—Doxorubicin—muscle cancer	0.0011	0.00131	CcSEcCtD
Cabergoline—Headache—Doxorubicin—muscle cancer	0.00109	0.0013	CcSEcCtD
Cabergoline—Nausea—Doxorubicin—muscle cancer	0.00104	0.00123	CcSEcCtD
